Moving Toward Personalized Medicine in Castration-Resistant Prostate Cancer
Recent advances in research technologies have allowed improved molecular characterization of castration-resistant prostate cancer (CRPC). These efforts hold promise for development of therapies that target alterations unique to an individual…